Drug Approval | May 07, 2026
The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
The private funding rose 38% amid growing international collaborations and CDMO demand
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Subscribe To Our Newsletter & Stay Updated
